1. Home
  2. PHVS vs LBRT Comparison

PHVS vs LBRT Comparison

Compare PHVS & LBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • LBRT
  • Stock Information
  • Founded
  • PHVS 2015
  • LBRT 2011
  • Country
  • PHVS Switzerland
  • LBRT United States
  • Employees
  • PHVS N/A
  • LBRT N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • LBRT Oilfield Services/Equipment
  • Sector
  • PHVS Health Care
  • LBRT Energy
  • Exchange
  • PHVS Nasdaq
  • LBRT Nasdaq
  • Market Cap
  • PHVS 1.6B
  • LBRT 1.8B
  • IPO Year
  • PHVS 2021
  • LBRT 2018
  • Fundamental
  • Price
  • PHVS $22.08
  • LBRT $18.94
  • Analyst Decision
  • PHVS Buy
  • LBRT Buy
  • Analyst Count
  • PHVS 6
  • LBRT 10
  • Target Price
  • PHVS $36.50
  • LBRT $16.10
  • AVG Volume (30 Days)
  • PHVS 217.1K
  • LBRT 6.4M
  • Earning Date
  • PHVS 11-12-2025
  • LBRT 10-16-2025
  • Dividend Yield
  • PHVS N/A
  • LBRT 2.11%
  • EPS Growth
  • PHVS N/A
  • LBRT N/A
  • EPS
  • PHVS N/A
  • LBRT 1.13
  • Revenue
  • PHVS N/A
  • LBRT $3,910,953,000.00
  • Revenue This Year
  • PHVS N/A
  • LBRT N/A
  • Revenue Next Year
  • PHVS N/A
  • LBRT N/A
  • P/E Ratio
  • PHVS N/A
  • LBRT $15.11
  • Revenue Growth
  • PHVS N/A
  • LBRT N/A
  • 52 Week Low
  • PHVS $11.51
  • LBRT $9.50
  • 52 Week High
  • PHVS $26.33
  • LBRT $23.58
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 49.23
  • LBRT 78.12
  • Support Level
  • PHVS $22.38
  • LBRT $16.43
  • Resistance Level
  • PHVS $23.64
  • LBRT $17.79
  • Average True Range (ATR)
  • PHVS 1.28
  • LBRT 1.08
  • MACD
  • PHVS 0.04
  • LBRT 0.36
  • Stochastic Oscillator
  • PHVS 61.27
  • LBRT 98.48

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About LBRT Liberty Energy Inc.

Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.

Share on Social Networks: